NL-OMON50157
Completed
Phase 4
ASsesment of Platelet function and Inhibition in patients Recovering from severe INfection - ASPIRIN-trial
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Acute myocardial infarction
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 97
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in the main\-trial, a subject must meet
- •all of the following criteria:
- •Primary clinical diagnosis of pneumonia
- •Primary clinical diagnosis of invasive urinary tract infection
- •Primary clinical diagnosis of cutaneous infection
- •18 years or older on the date of hospital presentation
- •Hospitalization for at least 24 hours
- •Having received at least 1 dose of antibiotics within 48 hours of admission.
- •In order to be eligible to participate in the sub\-study, a subject must meet
- •all of the following criteria:
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in the main\-trial:
- •\- Active metastatic cancer (c.q. malignancy)
- •\- Allergy to salicylate
- •\- Platelet count \<120\*109/l
- •\- History of non\-traumatic major bleeding
- •\- Known bleeding diathesis
- •\- Conditions which require antiplatelet therapy
- •\- Usage of antiplatelet therapy
- •\- Surgery 1 month prior to diagnosis
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
Evaluation of platelet activity in patients recovering from a severe infectioHyperaggregability of thrombocytes triggered by severe infection (i.e. pneumonia or invasive urinary tract infection or a cutaneous infection).Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2016-004303-32-NLVU university medical center62
Recruiting
N/A
Platelet-activation and optimal inhibition in patients with Atrial Fibrillation undergoing LAA closure; The POPULAR-LAAO trialAfibAtrial fibrillation10007521NL-OMON49947Sint Antonius Ziekenhuis120
Completed
N/A
Inhibitory efficacy in platelet aggregation and pharmacokinetics of single oral administration of 300mg clopidogrel and 20mg prasugrelIschemic heart diseases with PICJPRN-UMIN000014161Kazuo Umemura Center for clinical research Hamamatsu University Hospital50
Not Yet Recruiting
Phase 4
The magnitude of platelet inhibition and the pharmacokinetics of a 600 mg loading dose of clopidogrel, in different patient categories (stable angina versus acute-coronary syndromes versus ST-elevated myocardial infarction).patients with a history of a stent thrombosis1003553410011082NL-OMON33697Cardiology200
Completed
Phase 2
A Study of Acute Coronary Syndrome PatientsCTRI/2010/091/000348Eli Lilly210